These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23973814)
1. Multimodal delivery of irinotecan from microparticles with two distinct compartments. Rahmani S; Park TH; Dishman AF; Lahann J J Control Release; 2013 Nov; 172(1):239-245. PubMed ID: 23973814 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery. Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. Tsai M; Lu Z; Wientjes MG; Au JL J Control Release; 2013 Dec; 172(3):737-44. PubMed ID: 24056144 [TBL] [Abstract][Full Text] [Related]
7. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds. Hu Y; Hollinger JO; Marra KG J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815 [TBL] [Abstract][Full Text] [Related]
8. Controlled release of GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery. Abu-Awwad HAM; Thiagarajan L; Dixon JE Acta Biomater; 2017 Jul; 57():225-237. PubMed ID: 28457961 [TBL] [Abstract][Full Text] [Related]
9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
10. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan. Li Z; Xiong F; He J; Dai X; Wang G Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030 [TBL] [Abstract][Full Text] [Related]
11. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Fu K; Pack DW; Klibanov AM; Langer R Pharm Res; 2000 Jan; 17(1):100-6. PubMed ID: 10714616 [TBL] [Abstract][Full Text] [Related]
12. Drug release from a pH-sensitive multiblock co-polymer thermogel. Garripelli VK; Namgung R; Kim WJ; Jo S J Biomater Sci Polym Ed; 2012; 23(12):1505-19. PubMed ID: 21771392 [TBL] [Abstract][Full Text] [Related]
13. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system. Sweet JL; Pillay V; Choonara YE Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019 [TBL] [Abstract][Full Text] [Related]
14. Red blood cell membrane-camouflaged poly(lactic-co-glycolic acid) microparticles as a potential controlled release drug delivery system for local stellate ganglion microinjection. Liu B; Zhang D; Tu H; Alimi OA; Kong Y; Satyanarayana R; Kuss M; Li Y; Duan B Acta Biomater; 2023 Apr; 161():201-212. PubMed ID: 36858164 [TBL] [Abstract][Full Text] [Related]
15. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558 [TBL] [Abstract][Full Text] [Related]
16. Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model. Mallery SR; Shenderova A; Pei P; Begum S; Ciminieri JR; Wilson RF; Casto BC; Schuller DE; Morse MA Anticancer Res; 2001; 21(3B):1713-22. PubMed ID: 11497251 [TBL] [Abstract][Full Text] [Related]
17. Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel. Ozeki T; Hashizawa K; Kaneko D; Imai Y; Okada H Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1142-7. PubMed ID: 20823591 [TBL] [Abstract][Full Text] [Related]
19. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents. Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898 [TBL] [Abstract][Full Text] [Related]
20. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]